Login

Company 'Latvijas Gāze' is reluctant to easily part with the one and a half million lati fine imposed by the Competition Council. 00:10:00

Share On Facebook Share On Twitter

Aigars Kalvītis is Chairman of the Board

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Welcome Message from H.E. Akylbek Kamaldinov, Kazakhstan's Ambassador to Canada
00:10:00
From venture syndicates to funds with Climate|Sundeep Ahuja,General Partner,Climate Capital
00:10:00
Pekka Vauramo Appointed President and CEO of Metso | Pekka Vauramo, PRESIDENT AND CEO of Metso Canada Inc.
00:10:00
Yves Discusses Vision Lithium's Projects & Quebec's Mining Potential | YVES J. ROUGERIE - President and Chief Executive Officer of Vision Lithium Inc.
00:10:00
Mastering Productivity and Focus: Insights from Cal Newport on Eliminating Distractions and Deep Work
00:10:00
Premium Office Space Available at M1 Connect Business Hub, Northern Gold Coast
00:10:00
C4XD aims to efficiently deliver world leading immunoinflammatory medicines|Clive Dix,CEO,C4X Discovery Holdings
00:10:00
Nuveen is a global investment leader, managing an array of public and private assets for clients around the world and on behalf of our parent company TIAA , one of the world’s largest institutional investors,1 a highly-rated2 insurance company and a retir
00:10:00
"Strategic Insights for 2024: Goldman Sachs Leaders on Cash, US Assets, and Alternatives"
00:10:00
Cramer engages with AeroVironment CEO Wahid Nawabi, offering insights exclusively on CNBC PRO.
00:10:00
Why Choose Legacy Financial Strategies? | Michael Lutz, CEO, Legacy Financial Strategies, LLC.
00:10:00
supporting, mentoring, and investing in companies and startups at all stages of growth|Bill Liao, General Partner, venture fund SOSV

© 2017 - Neuhu+